$ATOS

$2.18▲ -0.9% YTD

1 SEC 13D/G filing tracked · Last updated Sep 24, 2026

Filing History

ATOS ▼ -0.9% - Atossa Therapeutics, Inc.

CP $2.18▲ -0.9%Sep 24, 2026 · ThinkSabio Blog

$ATOS ATOS - Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Agin…